−10.3
Protalix BioTherapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−25.0
FY23:
−1.32
FY24:
8.67
FY25:
−12.0
Change from FY21 to FY25
millions USD
FY21:
18.9
FY22:
−5.04
FY23:
−16.7
FY24:
4.22
FY25:
−2.37
Change from FY21 to FY25
millions USD
FY21:
12.1
FY22:
8.24
FY23:
24.7
FY24:
−16.8
FY25:
9.33
millions USD
FY21:
20.7
FY22:
−21.9
FY23:
6.52
FY24:
−3.87
FY25:
−5.08
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.7
FY22:
−25.6
FY23:
−2.47
FY24:
7.39
FY25:
−13.6
All amounts in millions USD